News & Articles

Delivers major improvements for discoveries in immunology, oncology, autoimmunity, and infectious diseases

Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine

Scientists are harnessing machine learning to make accurate measurements of breast cancer risk from a patient’s blood cells

binx health’s proven molecular io platform combined with SHERLOCK CRISPR technology will enable rapid, accurate testing for SARS-CoV-2 in retail and near-patient settings

The partnership aims to provide accessible solutions for labs involved in COVID-19 testing

Reliable, easy-to-use cryo-EM workflow solution promises to quadruple throughput for pharma labs

The exciting new automated product is designed to harness the power of flow chemistry to deliver more compounds faster

The company is providing well-characterized and standardized human primary cells with matching specialty cell culture media

Roche will access SpeeDx existing tests and technology to expand diagnostic products for the management of antibiotic resistance in STIs

Additional real-world data demonstrate meaningful outcomes for people living with diabetes who use Abbott's glucose sensing technology

The RECOVERY trial has shown that the cheap and widely available steroid cut deaths by one-third among patients critically ill with COVID-19

It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers

Company exploring further additional global capacity to provide broad and equitable access

Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide

Watch this on-demand webinar to discover how mass cytometry can be used to monitor immune responses to new therapeutics

LifeShare Blood Center deploys Biolog-id’s cutting-edge technology providing digital visibility to convalescent plasma containing antibodies from recovered COVID-19 patients

This aims to assist labs involved with the essential RT-PCR assay part of the “test, trace and isolate” strategy

The partnership aims to drive digital health collaborations, including artificial intelligence-enabled applications

Our expert webinar series aims to help you get the most from your drug discovery research

The RECOVERY trial has shown that hydroxychloroquine is not an effective treatment in patients hospitalized with COVID-19

This aims to make use of its collective and accumulated knowledge of graphene to fight the current pandemic

New version of their structure-based design platform aims to perform faster Free Energy Perturbation (FEP) calculations

Proving that the best thing comes in small packages, the compact chromatograph aims to deliver reliable performance